GMP Tips

A portal for Good Manufacturing Practice compliance tips for the Life Sciences industries.

GMP Tips header image 4

Entries from June 28th, 2010

Ineffective Line Clearance cited by FDA in Warning Letter

June 28th, 2010 · No Comments · Uncategorized

FDA discovered tablets left from previous runs in packaging and labeling equipment. This is among several violations listed in a Warning Letter issued to L. Perrigo Company by FDA. They also shipped tablets contaminated with metal shavings. GMP Tip Read Warning Letters like this one to see what FDA considers important and how FDA interprets [...]

[Read more →]

Tags:

American Red Cross Fined for GMP Violations – AGAIN!

June 28th, 2010 · No Comments · Uncategorized

FDA has fined the American Red Cross $16M for GMP violations. FDA has already sent 12 letters and imposed over $21M in fines since 2003, not including this latest fine. GMP Tip The American Red Cross is caught up in a costly cycle of non-compliance. Preventing contamination, mix-ups, and errors is ALWAYS less expensive than [...]

[Read more →]

Tags:

Your QC Program is Not Adequate – FDA Tells Company

June 21st, 2010 · No Comments · Uncategorized

In what appears to be the first Warning Letter issued for violations of 21CFR Part 111, GMP for Dietary Supplements, FDA cited Coats International Holdings, Inc. for seven major violations. Observation Four says “Your Quality Control program is not adequate” and goes on to cite four specific examples. GMP Tip Learn how FDA is enforcing [...]

[Read more →]

Tags:

FDA Commissioner on Innovation

June 15th, 2010 · No Comments · Uncategorized

Recently FDA Commissioner Margaret Hamburg spoke at the Massachusetts Medical Society on Innovation at the FDA: Past, Present, and Future. She does a nice job of describing the historical events leading to today’s FDA approach. GMP Tip Read Commissioner Hamburg’s speech and pick up some content you can incorporate into your GMP training sessions. To [...]

[Read more →]

Tags:

Genzyme’s Consent Decree – Read all 44 pages here

June 7th, 2010 · No Comments · Uncategorized

On May 24, 2010, Genzyme Corporation signed a Consent Decree of Permanent Injunction in the United States District Court (Massachusetts) and agreed to pay a fine of $175M to the United States Treasury. GMP Tip Learn from other companies experiences and gain insights into FDA’s thinking. Read this 44-page Consent Decree. Go to: www.gmptrainingsystems.com/resources Click [...]

[Read more →]

Tags:

FDA’s Sharfstein explains GMP in Congressional Testimony

June 1st, 2010 · No Comments · Uncategorized

FDA’s Principal Deputy Commissioner Joshua Sharfstein, M.D., testified at a Congressional Hearing on Johnson and Johnson’s recall of children’s Tylenol and other children’s medicines. In his testimony, Dr. Sharfstein does an excellent job of explaining the importance of GMP. At this same hearing, Congressman Edolphus Towns said he would be introducing legislation to give FDA [...]

[Read more →]

Tags: